How low can you go? Newly launched dashboard explores 340B’s deeply discounted drug prices
New report digs into Medicare's $200 billion in gross drug expenditures
As CMS drug pricing data remains missing, 46brooklyn finds solace in deflating generic drug costs
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, WAC, Rebates, Utilization, Spread, Acthar, Nuwiq, Wilate, Perseris, Lopid, Paliperidone, Duloxetine, Buprenorphine-Naloxone, Hydroxyzine, Gabapentin
Drug pricing for your ears: The 46brooklyn Podcast is officially launched!
Examining the first month of 2022 brand drug price increases
Ben LinkBrand drugs, List prices, WAC, Rebates, Aduhelm, Medicaid, AbbVie, Humira, Biktarvy, Vyvanse, Auvi-Q, Biogen, Micardis, Admelog, Insulin
The highs and lows of the final drug price changes of 2021
Ben LinkNADAC, Medicaid, Generic, Brand drugs, List prices, WAC, Rebates, Utilization, Ingrezza, Adcetris, Vascepa, Santyl, Methylphenidate, sevelamer, venlafaxine, ethosuximide, perphenazine, celecoxib, entecavir
Examining 2021's brand drug price increases and sneaking a peak at the early price hikes of 2022
Ben LinkBrand drugs, List prices, WAC, Rebates, Aduhelm, Medicaid, Latuda, Vimpat, Keytruda, Biktarvy
Naughty or nice? Here are the drug price changes we found in our stockings.
New drug pricing report showcases highs, lows, distorted incentives, and brokenness of Medicare Part D
